Urticaria pigmentosa associated with acute stress and lesional skin mast-cell expression of CRF-R1

Clinical and Experimental Dermatology

Volumn 34, Issue 5, 2009, Pages

  Theoharides, T C ^a,e   Kempuraj, D ^a   Marchand, J ^a   Tzianoumis, L ^b   Vasiadi, M ^a   Katsarou Katsari, A ^d   Makris, M ^c   Kalogeromitros, D ^c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Ygeias Melathron General Clinic of Typet   (Greece)

^c Allergy Clinical Research Center   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGONOT PLUS; ANTIBODY; ATORVASTATIN; BROMAZEPAM; CHOLESTEROL; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; DOXEPIN; HYDROXYZINE; IMATINIB; METHYLPREDNISOLONE; QUERCETIN; STEM CELL FACTOR RECEPTOR; THYROID PEROXIDASE ANTIBODY; THYROXINE; TRYPTASE; UNCLASSIFIED DRUG;

ACUTE STRESS; ADULT; ANXIETY DISORDER; ARTICLE; BEDTIME DOSAGE; CASE REPORT; CELL ACTIVATION; CELL POPULATION; CHOLESTEROL BLOOD LEVEL; DIARRHEA; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; FEMALE; FLUSHING; GIEMSA STAIN; HEADACHE; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAST CELL; MAST CELL DEGRANULATION; MASTOCYTOSIS; MENTAL STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PRURITUS; SKIN BIOPSY; SKIN DEFECT; STATE TRAIT ANXIETY INVENTORY; SYMPTOM; URTICARIA PIGMENTOSA;

ACUTE DISEASE; ADULT; FEMALE; HUMANS; MAST CELLS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SKIN; STRESS, PSYCHOLOGICAL; URTICARIA PIGMENTOSA;

EID: 66449115211     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2008.03043.x     Document Type: Article

References (11)

1. Castells M, Austen KF. Mastocytosis: mediator-related signs and symptoms. Int Arch Allergy Immunol 2002 127 : 147 52.
2. Akin C, Valent P, Escribano L. Urticaria pigmentosa and mastocytosis: the role of immunophenotyping in diagnosis and determining response to treatment. Curr Allergy Asthma Rep 2006 6 : 282 8.
3. Slominski A, Wortsman J, Luger T et al. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 2000 80 : 979 1020. (Pubitemid 30452009)
4. Theoharides TC, Singh LK, Boucher W et al. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its pro-inflammatory effects. Endocrinology 1998 139 : 403 13.
5. Cao J, Papadopoulou N, Kempuraj D et al. Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J Immunol 2005 174 : 7665 75.
6. Droogendijk HJ, Kluin-Nelemans HJ, van Doormaal JJ et al. Imatinib mesylate in the treatment of systemic mastocytosis: a phase II trial. Cancer 2006 107 : 345 51.
7. Annesi-Maesano I, Beyer A, Marmouz F et al. Do patients with skin allergies have higher levels of anxiety than patients with allergic respiratory diseases? Results of a large-scale cross-sectional study in a French population. Br J Dermatol 2006 154 : 1128 36.
8. Donelan J, Boucher W, Papadopoulou N et al. Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process. Proc Natl Acad Sci USA 2006 103 : 7759 64.
9. Crompton R, Clifton VL, Bisits AT et al. Corticotropin-releasing hormone causes vasodilation in human skin via mast cell-dependent pathways. J Clin Endocrinol Metab 2003 88 : 5427 32.
10. Slominski A, Zbytek B, Zmijewski M et al. Corticotropin releasing hormone and the skin. Front Biosci 2006 11 : 2230 48.
11. Paus R, Theoharides TC, Arck PC. Neuroimmunoendocrine circuitry of the 'brain-skin connection'. Trends Immunol 2006 27 : 32 9.